$3M Jury Verdict Against GSK in Landmark Paxil Suicide Case

April 20, 2017, Chicago, Illinois - - A federal jury has sided with the widow of a deceased Chicago attorney in her generic Paxil suicide lawsuit against GlaxoSmithKline (GSK), ordering the pharmaceutical giant to pay $3 million. The jury verdict resolves allegations in the trial of Dolin v. Smithkline Beecham [...]

Monsanto Cancer Lawsuits Consolidated in Northern California

Los Angeles, California – The U.S. Judicial Panel on Multidistrict Litigation (JPML) for the Northern District of California has today consolidated 37 lawsuits that allege exposure to Monsanto’s Roundup weed killer causes cancer. The JPML consolidated the lawsuits in Northern California where two of the earliest Monsanto cancer lawsuits were [...]

By | October 23rd, 2016|Blog, Monsanto Roundup News, Press Releases, R. Brent Wisner|

Plaintiffs File Motion to Consolidate Roundup Cancer Lawsuits Against Monsanto

Los Angeles, California - - Plaintiffs who have filed lawsuits against Monsanto Co. over a carcinogenic ingredient found in the company’s herbicide, Roundup weed killer, are asking for their cases to be consolidated into a multidistrict litigation (MDL) in Los Angeles, California. Over a dozen lawsuits against Monsanto have been filed [...]

By | August 3rd, 2016|Blog, Monsanto Roundup News, R. Brent Wisner|

Antidepressant Suicide – A Catch-22

Justice has been served! $3 Million jury verdict against GSK in landmark generic Paxil suicide case What’s wrong with this picture? Company A designs a drug. The company develops it, tests it on animals and ultimately humans, and sends the results of their research—or what they claim are the results—to [...]

By | July 20th, 2016|Blog, Paxil News, Pharma News, R. Brent Wisner|

Monsanto Roundup Lawyer Brent Wisner Interviewed on KFCF 88.1 FM

Monsanto Roundup lawyer Brent Wisner and his client, Teri McCall, were interviewed this week by KFCF 88.1 FM’s Lloyd Carter to discuss ongoing litigation against Monsanto, the manufacturer of Roundup weed killer. Monsanto has been named in a number of lawsuits alleging the agrochemical giant purposely downplayed the link between cancer [...]

By | April 14th, 2016|Blog, Monsanto Roundup News, R. Brent Wisner|

Eli Lilly Misled Consumers about Cymbalta Withdrawal, According to Dozens of Lawsuits Filed Across the U.S.

We are no longer accepting new Cymbalta withdrawal cases. Update: Federal Judge Denies Summary Judgment in Cymbalta Withdrawal Cases, Sets Cases for Trial in August Los Angeles, California, August 14, 2014 - - Dozens of personal injury lawsuits have been filed across the country by consumers [...]

By | August 14th, 2014|Cymbalta News, R. Brent Wisner|

Widow’s Lawsuit Against GSK Alleges Weak Warning Label on Common Antidepressant

Justice has been served! $3 Million jury verdict against GSK in landmark generic Paxil suicide case NBC 5 News Chicago interviewed antidepressant lawyer, Brent Wisner, about the tragic suicide of prominent Chicago attorney Stewart Dolin. On July 15, 2010, Mr. Dolin took his life after taking the prescribed generic antidepressant [...]

By | May 28th, 2014|Paxil News, Pharma News, R. Brent Wisner|

Settlement of Missouri Celexa® and Lexapro® Class Action Lawsuit Announced

March 26, 2014 - - Plaintiffs’ attorneys in a class action involving Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. (collectively, “Forest”) announced that they have reached a settlement of claims relating to the past marketing of the antidepressants Celexa® and Lexapro® for use by minors in Missouri.  A settlement fund ranging [...]

Federal Judge Certifies Celexa / Lexapro Pediatric Antidepressant Class Action

A federal judge has certified a class action lawsuit filed by two mothers from Missouri alleging that Forest Pharmaceuticals, Inc. and Forest Laboratories, Inc. “misrepresented and concealed” information concerning the effectiveness of two company drugs for the treatment of depression in pediatric patients. The plaintiffs, represented by the law firms Baum, [...]

Forest Pharmaceuticals Can’t Stop Missouri Pediatric Antidepressant Class Action

January 10, 2014 -- A Massachusetts federal judge has certified a class action lawsuit filed by two Missouri mothers who accuse Forest Pharmaceuticals, Inc. of "misrepresenting and concealing" information regarding the effectiveness of two company drugs prescribed to treat depression in pediatric patients.  The mothers, who are represented by the law [...]